Recombinant multi-species PCAF/KAT2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PCAF/KAT2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation. [provided by RefSeq, Jul 2008]
The Alternative Names of target: A930006P13Rik,AABR07066180.1,CAF,Histone acetyltransferase KAT2B,Histone acetyltransferase PCAF (Histone acetylase PCAF),KAT2B,Kat2b,Lysine acetyltransferase 2B,P/CAF,P300/CBP-associated factor (P/CAF),PCAF,Pcaf,Spermidine acetyltransferase KAT2B,p/CAF

Target products collectionGo to PCAF/KAT2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T16902-Ag-1/ GM-Tg-hg-T16902-Ag-2 Human PCAF/KAT2B protein Human
GM-Tg-rg-T16902-Ag-1/ GM-Tg-rg-T16902-Ag-2 Rat PCAF/KAT2B protein Rat
GM-Tg-mg-T16902-Ag-1/ GM-Tg-mg-T16902-Ag-2 Mouse PCAF/KAT2B protein Mouse
GM-Tg-cynog-T16902-Ag-1/ GM-Tg-cynog-T16902-Ag-2 Cynomolgus/Rhesus macaque PCAF/KAT2B protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T16902-Ag-1/ GM-Tg-felg-T16902-Ag-2 Feline PCAF/KAT2B protein Feline
GM-Tg-cang-T16902-Ag-1/ GM-Tg-cang-T16902-Ag-2 Canine PCAF/KAT2B protein Canine
GM-Tg-bovg-T16902-Ag-1/ GM-Tg-bovg-T16902-Ag-2 Bovine PCAF/KAT2B protein Bovine
GM-Tg-equg-T16902-Ag-1/ GM-Tg-equg-T16902-Ag-2 Equine PCAF/KAT2B protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T16902-Ag-1/ GM-Tg-hg-T16902-Ag-2; GM-Tg-rg-T16902-Ag-1/ GM-Tg-rg-T16902-Ag-2;
GM-Tg-mg-T16902-Ag-1/ GM-Tg-mg-T16902-Ag-2; GM-Tg-cynog-T16902-Ag-1/ GM-Tg-cynog-T16902-Ag-2;
GM-Tg-felg-T16902-Ag-1/ GM-Tg-felg-T16902-Ag-2; GM-Tg-cang-T16902-Ag-1/ GM-Tg-cang-T16902-Ag-2;
GM-Tg-bovg-T16902-Ag-1/ GM-Tg-bovg-T16902-Ag-2; GM-Tg-equg-T16902-Ag-1/ GM-Tg-equg-T16902-Ag-2
Products Name PCAF/KAT2B protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PCAF/KAT2B
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PCAF/KAT2B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.